πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

280 results for β€œLB” Clear

  1. Valbenazine

    NEUROCRINE BIOSCIENCES INC

    Tardive Dyskinesia (TD)

    approved small molecule completed

    2 trials

  2. Valbenazine

    NEUROCRINE BIOSCIENCES INC

    Schizophrenia

    approved small molecule active

    3 trials

  3. Valbenazine Oral Capsule

    NEUROCRINE BIOSCIENCES INC

    Tardive Dyskinesia

    approved small molecule terminated

    1 trial

  4. albumin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule active

    1 trial

  5. minimally invasive cholecystolithotomy with gallbladder reservation

    The First People's Hospital of Lianyungang

    Gallstones

    approved other active

    1 trial

  6. telbivudine (ROADMAP)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B, Chronic

    approved small molecule active

    1 trial

  7. Acetaminophen

    Hospital Authority, Hong Kong

    Elbow Fracture

    small molecule completed

    1 trial

  8. Albumin Human

    United Therapeutics Europe Ltd

    Burn Injury

    small molecule completed

    1 trial

  9. Albumin paclitaxel/neutrophil drug

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    mab active

    1 trial

  10. Albumin-Bound Paclitaxel

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastric Carcinoma

    small molecule active

    1 trial

  11. Albuterol

    The First People's Hospital of Lianyungang

    Chronic Obstructive Pulmonary Disease

    small molecule active

    1 trial

  12. Albuterol eMDPI DS

    Teva Pharma GmbH

    Pulmonary Disease, Chronic Obstructive

    other completed

    1 trial

  13. T, 260 mg/m2, paclitaxel for injection (albumin-bound)

    The First People's Hospital of Lianyungang

    Breast Cancer

    small molecule active

    1 trial

  14. Telbivudine

    Chinese University of Hong Kong

    Chronic Hepatitis B

    small molecule terminated

    1 trial

  15. salbutamol

    The First People's Hospital of Lianyungang

    Liver Transplantation

    small molecule active

    1 trial

  16. Ξ²-hydroxy Ξ²-methylbutyrate (HMB) supplement

    Chinese University of Hong Kong

    Sarcopenia

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources